Gilead Sciences Approves Funds to Expand CAP’s Aging Well Program


Portland, OR (November 16th, 2018) – Cascade AIDS Project (CAP) is very pleased to announce a partnership with Gilead Sciences, Inc. for the 2018-2021 Aging Well Program. Gilead is funding the three-year $375,000 program that focuses on supporting the wellbeing of aging adults living with and affected by HIV.

The Aging Well Program will mobilize long-term survivors, create a coalition of professionals in related fields, host educational/social events for survivors, improve communication and information sharing, and evaluate efforts – all focused on aging adults. The program also aims to directly reach aging adults living with and affected by HIV through a Long-Term Survivor Leadership Caucus and several social/educational events. Further the program aims to engage professionals working in HIV services and allied disciplines annually through a newly formed Oregon Aging Well with HIV Coalition. Finally, the program will have a broad communications campaign consisting of an Aging Well website, social media activities and print publications.

CAP Executive Director, Tyler TerMeer, says “we recognize the tremendous need for this program as the face of HIV in the county shifts to a population of older individuals living for many decades beyond their initial diagnosis. Many never expected to live to an old age and today find themselves unprepared to be aging well. Supporting their health and wellbeing is a key component of CAP’s mission and we thank Gilead for giving us the opportunity to do this work.

“Comprehensive programs for aging people living with HIV are essential to reducing the comorbidities they face, including those with limited access to quality healthcare “said Gregg Alton, Chief Patient Officer at Gilead Science. “Through our continued partnership with CAP, we aim to have a long-term impact on the overall health and well-being of aging people living with HIV, as well as to increase their quality of life.”

Read the full press release here.